30.06.2014 Views

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ANTIPROTOZOAL DRUGS<br />

Table 10.6 <strong>Clinical</strong> applications and dose rates of antiprotozoal drugs in dogs and cats (continued)<br />

Benznidazole (classified as a 2-nitroimidazole)<br />

Trypanosoma cruzi 5–7 mpk PO q.24 h 2 months<br />

After oral administration to dogs, rapid and complete absorption has been observed with T max at 1–5 h. The drug is widely distributed,<br />

concentrating 4–7-fold in a variety of tissues, including lung, kidney, liver and brain. Elimination half-life is 6–10 h. Reported to have fewer<br />

side effects than nifurimox.<br />

PENTAVALENT ANTIMONIALS<br />

Available drugs are prepared by reacting gluconic acid (sodium stibogluconate) or meglumine (N-methyl-d-glucamine; meglumine<br />

antimonate) with pentavalent antimony. The reaction mixture is allowed to age and a complex mixture of antimony-sugar polymeric<br />

compounds is isolated. The dose rate of either compound is designed to deliver equal Sb v doses.<br />

Meglumine antimonate<br />

Leishmaniasis 50–75 mg/kg IM or SC q.12 h for 10 days. Best activity associated with combined use with allopurinol.<br />

Sodium stibogluconate (antimony sodium gluconate)<br />

Leishmaniasis 30–50 mg/kg q.24 h SC, IV 20–30 days<br />

POLYENE ANTIFUNGAL<br />

See Chapter 9, Systemic Antifungal Therapy<br />

Amphotericin B<br />

Leishmaniasis Dose rates are 1–2 times higher than those recommended for the treatment of systemic mycoses in dogs.<br />

PURINE ANALOG<br />

Allopurinol<br />

Leishmaniasis 15 mg/kg q.12 h PO 3–6 months; 6–10 mg/kg q.8 h PO 3–24 months; maintenance treatment 20 mg/kg q.24 h, 1 week per<br />

month.<br />

THIAMINE INHIBITOR<br />

Amprolium<br />

Cystoisospora infections in dogs and cats 300–400 mg/kg PO q.24 h 5 days<br />

TRIAZINES/BENZENE ACETONITRILES<br />

Triazines interfere with normal apicomplexan parasite division, leading to the presence of multinucleate schizonts, within which large vacuoles<br />

develop before they eventually degenerate. This class (originally developed as herbicides) may act on enzyme pathways (respiratory chain<br />

and pyrimidine synthesis) within apicoplasts and mitochondria.<br />

Toltrazuril<br />

Cystoisospora 5–10 mg/kg PO (single dose)<br />

Hepatozoon canis (and possibily Neospora caninum) 5–10 mg/kg PO q.24 h for 2–6 days<br />

Toltrazuril is a broad-spectrum antiprotozoal drug widely used for coccidiosis control in poultry and pigs. The drug is slowly absorbed after<br />

oral administration and has prolonged elimination with a half-life of several days. It has been observed that the outcome of treatment of<br />

neosporosis is improved if T cell function is normal. Other members of the class include diclazuril and the active toltrazuril metabolite<br />

ponazuril.<br />

ANTIBACTERIAL DRUGS WITH ANTIPROTOZOAL ACTIVITY<br />

The recent finding of a remnant chloroplast (the plastid or apicoplast) in most apicomplexan protozoa helps to explain the presence of many<br />

(but not all) antibacterial prokaryotic drug targets in eucaryotic protozoa. Further details of pharmacology are presented in Chapter 8.<br />

Aminoglycoside<br />

Paromomycin<br />

Cryptosporidiosis 125–165 mg/kg PO q.12 h 5 days<br />

Absorption from gastrointestinal tract usually poor. However, acute renal failure has been described in cats. Used topically and parenterally in<br />

humans to treat cutaneous and visceral leishmaniasis respectively.<br />

Dihydrofolate reductase inhibitor (diamino pyrimidine)<br />

Ormetoprim<br />

Cystoisospora spp 66 mg/kg q.24 h 7–23 days<br />

Combined with sulfadimethoxine in a ratio of 1 : 5 in tablets for dogs.<br />

Pyrimethamine<br />

Cats appear particularly sensitive to bone marrow suppression by pyrimethamine, and toxicity may be prevented or reduced by<br />

administration of folic acid or yeast supplements.<br />

Toxoplasma gondii Pyrimethamine 0.25–1 mg/kg PO q.24 h + trimethoprim/sulfonamide 15–30 mg/kg PO q.12 h 2–4 weeks<br />

Hepatozoon americanum Pyrimethamine 0.25 mg/kg q.24 h + trimethoprim/sulfadiazine 15 mg/kg PO q.12 h + clindamycin 10 mg/kg PO q.8 h<br />

14 days (relapses noted within 3–4 months) (+ decoquinate)<br />

Neospora caninum Pyrimethamine 1 mg/kg PO q.24 h + trimethoprim/sulfadiazine 15–30 mg/kg PO q.12 h 2–4 weeks<br />

Trimethoprim<br />

Acanthamoeba, Pneumocystis, Cystoisospora, Neospora and Toxoplasma (CNS and enteric forms) 15–30 mg/kg PO q.12 h 10–30 days in<br />

combination with a sulfonamide (usually sulfadiazine)<br />

239

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!